Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects
Clinical trial NCT01295320 · COMPLETED
Trial details
- NCT number
- NCT01295320
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-28
- Primary completion
- 2013-06-20
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.